Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...
Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III clinical trial of sparsentan for the ...
Provincial Management Provincial Authority (PDMA) issued a drought warning for the province of Sindh as the province received 52 percent less seasonal rains. PDMA registered 52 percent fewer rains ...
Shares of Bharat Petroleum Corporation (BPCL), Indraprastha Gas (IGL), Gail (India) were in focus on Tuesday, January 7, 2025. BPCL share price, today, rose 2 per cent (Rs 290.5 per share) in the ...
FUSO will be responsible for all development costs, submissions, and maintenance of the regulatory dossier with the Japanese Pharmaceutical and Medical Device Agency (PMDA), as well as all sales ...